Last reviewed · How we verify

Topiramate and N-Acetyl Cysteine

Nassima Ait-Daoud Tiouririne · Phase 1 active Small molecule

Topiramate and N-Acetyl Cysteine is a Small molecule drug developed by Nassima Ait-Daoud Tiouririne. It is currently in Phase 1 development. Also known as: Topamax.

At a glance

Generic nameTopiramate and N-Acetyl Cysteine
Also known asTopamax
SponsorNassima Ait-Daoud Tiouririne
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Topiramate and N-Acetyl Cysteine

What is Topiramate and N-Acetyl Cysteine?

Topiramate and N-Acetyl Cysteine is a Small molecule drug developed by Nassima Ait-Daoud Tiouririne.

Who makes Topiramate and N-Acetyl Cysteine?

Topiramate and N-Acetyl Cysteine is developed by Nassima Ait-Daoud Tiouririne (see full Nassima Ait-Daoud Tiouririne pipeline at /company/nassima-ait-daoud-tiouririne).

Is Topiramate and N-Acetyl Cysteine also known as anything else?

Topiramate and N-Acetyl Cysteine is also known as Topamax.

What development phase is Topiramate and N-Acetyl Cysteine in?

Topiramate and N-Acetyl Cysteine is in Phase 1.

Related